Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UrgentRx closes $17.5mm Series C round

Executive Summary

UrgentRx (also known as Breakthrough Products; markets portable single-dose OTC medications) raised $17.5mm in Series C funding. Led by an undisclosed family office, the financing also included previous investors Sam Zell, David Bonderman, Randall Kaplan (JUMP Investors), and Boulevard Capital Management.
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies